Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
H077 SR Tablets Vs Silodosin Capsules Safety and Efficacy In BPH
Details : H077 is a Other Small Molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Prostatic Hyperplasia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 28, 2025
Qianweitai (Silodosin) vs Tamsulosin for Benign Prostatic Hyperplasia
Details : Silodosin is a Other Small Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Prostatic Hyperplasia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 21, 2025
Lead Product(s) : H057
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : H057 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Bronchiectasis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 06, 2025
Lead Product(s) : H057
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HL-1186
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants
Details : HL-1186 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 04, 2025
Lead Product(s) : HL-1186
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
